- Home
- GOSS vs MYFW Comparison
GOSS vs MYFW Comparison
Compare GOSS & MYFW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- MYFW
- Stock Information
- Founded
- GOSS 2015
- MYFW 2002
- Country
- GOSS United States
- MYFW United States
- Employees
- GOSS N/A
- MYFW N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- MYFW Major Banks
- Sector
- GOSS Health Care
- MYFW Finance
- Exchange
- GOSS Nasdaq
- MYFW Nasdaq
- Market Cap
- GOSS 212.9M
- MYFW 198.1M
- IPO Year
- GOSS 2019
- MYFW 2018
- Fundamental
- Price
- GOSS $0.80
- MYFW $20.53
- Analyst Decision
- GOSS Strong Buy
- MYFW Buy
- Analyst Count
- GOSS 5
- MYFW 3
- Target Price
- GOSS $9.20
- MYFW $22.33
- AVG Volume (30 Days)
- GOSS 2.3M
- MYFW 17.2K
- Earning Date
- GOSS 11-07-2024
- MYFW 01-23-2025
- Dividend Yield
- GOSS N/A
- MYFW N/A
- EPS Growth
- GOSS N/A
- MYFW N/A
- EPS
- GOSS N/A
- MYFW 0.26
- Revenue
- GOSS $105,322,000.00
- MYFW $79,649,000.00
- Revenue This Year
- GOSS N/A
- MYFW N/A
- Revenue Next Year
- GOSS N/A
- MYFW $12.86
- P/E Ratio
- GOSS N/A
- MYFW $79.44
- Revenue Growth
- GOSS N/A
- MYFW N/A
- 52 Week Low
- GOSS $0.50
- MYFW $12.84
- 52 Week High
- GOSS $1.60
- MYFW $22.32
- Technical
- Relative Strength Index (RSI)
- GOSS 50.75
- MYFW 49.60
- Support Level
- GOSS $0.83
- MYFW $20.89
- Resistance Level
- GOSS $1.10
- MYFW $21.26
- Average True Range (ATR)
- GOSS 0.08
- MYFW 0.41
- MACD
- GOSS 0.02
- MYFW -0.11
- Stochastic Oscillator
- GOSS 31.66
- MYFW 7.69
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.